HOME

ABOUT KERYX

We are a biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products to address underserved needs.

Keryx is currently developing
KRX-0502, an investigational, ferric citrate, oral compound that binds to phosphate.

MISSION

mission_homepage.png

We recognize the potential of undervalued compounds and use our expertise to nurture products to reach maximum potential and deliver value to our company and our customers.

Learn more > 

INVESTORS